𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A department of veterans affairs cooperative study

✍ Scribed by Daniel O. Clegg; Domenic J. Reda; Michael H. Weisman; John J. Cush; Frank B. Vasey; H. Ralph Schumacher Jr.; Elly Budiman-Mak; Dominic J. Balestra; Warren D. Blackburn; Grant W. Cannon; Robert D. Inman; F. Paul Alepa; Edwin Mejias; Miriam R. Cohen; Rama Makkena; Maren L. Mahowald; Jean Higashida; Stuart L. Silverman; Nourollah Parhami; Joel Buxbaum; Clair M. Haakenson; Richard H. Ward; B. J. Manaster; Robert J. Anderson; John R. Ward; William G. Henderson


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
616 KB
Volume
39
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparison of sulfasalazine and placebo
✍ Daniel O. Clegg; Domenic J. Reda; Mazen Abdellatif πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 1 views

Objective. To determine if the peripheral articular manifestations of the seronegative spondylarthropathies (SNSA) respond differently than the axial manifestations to treatment with sulfasalazine (SSZ). Methods. This is a reanalysis of a previously reported series of randomized, double-blind, plac

Sulfasalazine in the treatment of juveni
✍ Marion A. J. van Rossum; Theo J. W. Fiselier; Marcel J. A. M. Franssen; Aeilko H πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 987 KB

Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula

Inter-rater reliability of the Abnormal
✍ Robert Edson; Philip Lavori; Daniel Bloch; Kathlene Tracy; Lenard A. Adler; John πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract The US Department of Veterans' Affairs (VA) conducted Cooperative Study #394 at nine sites to determine whether vitamin E was a safe and effective treatment for tardive dyskinesia (TD). The study used the Abnormal Involuntary Movement Scale (AIMS) to measure TD. To monitor inter‐rater r